Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C10orf67 antisense RNA 1 (C10orf67-AS1) is classified as a long non-coding RNA (lncRNA) of the antisense type, meaning it is transcribed from the DNA strand opposite to the coding gene C10orf67 and overlaps that region. Antisense RNAs in general function in the regulation of gene expression, usually by modulating the stability, translation, or transcription of their sense mRNA counterparts, or through epigenetic mechanisms such as attracting chromatin-modifying complexes. There are no experimental studies specifically characterizing the function or clinical relevance of C10orf67-AS1. Its disease associations, interactions, and utility as a therapeutic target or biomarker have not been documented in the available literature. It is not considered a receptor, enzyme, or drug target under current knowledge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C10orf67 antisense RNA 1 (C10orf67-AS1).